Vaccines and vaccination against tick-borne encephalitis

Herwig Kollaritsch, Maria Paulke-Korinek, Heidemarie Holzmann, Joachim Hombach, Bjarne Bjorvatn, Alan Barrett

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Tick-borne encephalitis (TBE) is an emerging viral zoonosis and is endemic from Japan, China, Mongolia and Russia, to Central Europe and France. There is no specific treatment and TBE can be fatal. The four licensed prophylactic vaccines are produced according to WHO manufacturing requirements. Large clinical trials and postmarketing surveillance demonstrated safety and efficacy of the two European vaccines. The two Russian vaccines showed their effectiveness in daily use, but limited published data are available on controlled clinical trials. Vaccination recommendations in endemic areas vary significantly. In some countries, public vaccination programs are implemented. The WHO has recently issued recommendations on evidence-based use of TBE vaccines. However, more data are needed regarding safety, efficacy and long-term protection after vaccination.

Original languageEnglish (US)
Pages (from-to)1103-1119
Number of pages17
JournalExpert Review of Vaccines
Volume11
Issue number9
DOIs
StatePublished - Sep 2012

Fingerprint

Tick-Borne Encephalitis
Vaccination
Vaccines
Mongolia
Safety
Russia
Controlled Clinical Trials
Zoonoses
France
China
Japan
Clinical Trials

Keywords

  • epidemiology
  • long-term protection
  • prophylaxis
  • tick-borne encephalitis
  • vaccination
  • vaccines

ASJC Scopus subject areas

  • Immunology
  • Drug Discovery
  • Pharmacology
  • Molecular Medicine

Cite this

Kollaritsch, H., Paulke-Korinek, M., Holzmann, H., Hombach, J., Bjorvatn, B., & Barrett, A. (2012). Vaccines and vaccination against tick-borne encephalitis. Expert Review of Vaccines, 11(9), 1103-1119. https://doi.org/10.1586/erv.12.86

Vaccines and vaccination against tick-borne encephalitis. / Kollaritsch, Herwig; Paulke-Korinek, Maria; Holzmann, Heidemarie; Hombach, Joachim; Bjorvatn, Bjarne; Barrett, Alan.

In: Expert Review of Vaccines, Vol. 11, No. 9, 09.2012, p. 1103-1119.

Research output: Contribution to journalArticle

Kollaritsch, H, Paulke-Korinek, M, Holzmann, H, Hombach, J, Bjorvatn, B & Barrett, A 2012, 'Vaccines and vaccination against tick-borne encephalitis', Expert Review of Vaccines, vol. 11, no. 9, pp. 1103-1119. https://doi.org/10.1586/erv.12.86
Kollaritsch H, Paulke-Korinek M, Holzmann H, Hombach J, Bjorvatn B, Barrett A. Vaccines and vaccination against tick-borne encephalitis. Expert Review of Vaccines. 2012 Sep;11(9):1103-1119. https://doi.org/10.1586/erv.12.86
Kollaritsch, Herwig ; Paulke-Korinek, Maria ; Holzmann, Heidemarie ; Hombach, Joachim ; Bjorvatn, Bjarne ; Barrett, Alan. / Vaccines and vaccination against tick-borne encephalitis. In: Expert Review of Vaccines. 2012 ; Vol. 11, No. 9. pp. 1103-1119.
@article{6fcbefca71c0451e863658cf26a5e3d9,
title = "Vaccines and vaccination against tick-borne encephalitis",
abstract = "Tick-borne encephalitis (TBE) is an emerging viral zoonosis and is endemic from Japan, China, Mongolia and Russia, to Central Europe and France. There is no specific treatment and TBE can be fatal. The four licensed prophylactic vaccines are produced according to WHO manufacturing requirements. Large clinical trials and postmarketing surveillance demonstrated safety and efficacy of the two European vaccines. The two Russian vaccines showed their effectiveness in daily use, but limited published data are available on controlled clinical trials. Vaccination recommendations in endemic areas vary significantly. In some countries, public vaccination programs are implemented. The WHO has recently issued recommendations on evidence-based use of TBE vaccines. However, more data are needed regarding safety, efficacy and long-term protection after vaccination.",
keywords = "epidemiology, long-term protection, prophylaxis, tick-borne encephalitis, vaccination, vaccines",
author = "Herwig Kollaritsch and Maria Paulke-Korinek and Heidemarie Holzmann and Joachim Hombach and Bjarne Bjorvatn and Alan Barrett",
year = "2012",
month = "9",
doi = "10.1586/erv.12.86",
language = "English (US)",
volume = "11",
pages = "1103--1119",
journal = "Expert Review of Vaccines",
issn = "1476-0584",
publisher = "Expert Reviews Ltd.",
number = "9",

}

TY - JOUR

T1 - Vaccines and vaccination against tick-borne encephalitis

AU - Kollaritsch, Herwig

AU - Paulke-Korinek, Maria

AU - Holzmann, Heidemarie

AU - Hombach, Joachim

AU - Bjorvatn, Bjarne

AU - Barrett, Alan

PY - 2012/9

Y1 - 2012/9

N2 - Tick-borne encephalitis (TBE) is an emerging viral zoonosis and is endemic from Japan, China, Mongolia and Russia, to Central Europe and France. There is no specific treatment and TBE can be fatal. The four licensed prophylactic vaccines are produced according to WHO manufacturing requirements. Large clinical trials and postmarketing surveillance demonstrated safety and efficacy of the two European vaccines. The two Russian vaccines showed their effectiveness in daily use, but limited published data are available on controlled clinical trials. Vaccination recommendations in endemic areas vary significantly. In some countries, public vaccination programs are implemented. The WHO has recently issued recommendations on evidence-based use of TBE vaccines. However, more data are needed regarding safety, efficacy and long-term protection after vaccination.

AB - Tick-borne encephalitis (TBE) is an emerging viral zoonosis and is endemic from Japan, China, Mongolia and Russia, to Central Europe and France. There is no specific treatment and TBE can be fatal. The four licensed prophylactic vaccines are produced according to WHO manufacturing requirements. Large clinical trials and postmarketing surveillance demonstrated safety and efficacy of the two European vaccines. The two Russian vaccines showed their effectiveness in daily use, but limited published data are available on controlled clinical trials. Vaccination recommendations in endemic areas vary significantly. In some countries, public vaccination programs are implemented. The WHO has recently issued recommendations on evidence-based use of TBE vaccines. However, more data are needed regarding safety, efficacy and long-term protection after vaccination.

KW - epidemiology

KW - long-term protection

KW - prophylaxis

KW - tick-borne encephalitis

KW - vaccination

KW - vaccines

UR - http://www.scopus.com/inward/record.url?scp=84869435167&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84869435167&partnerID=8YFLogxK

U2 - 10.1586/erv.12.86

DO - 10.1586/erv.12.86

M3 - Article

VL - 11

SP - 1103

EP - 1119

JO - Expert Review of Vaccines

JF - Expert Review of Vaccines

SN - 1476-0584

IS - 9

ER -